These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11642310)

  • 1. Shark cartilage as source of antiangiogenic compounds: from basic to clinical research.
    González RP; Leyva A; Moraes MO
    Biol Pharm Bull; 2001 Oct; 24(10):1097-101. PubMed ID: 11642310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of low-molecular-weight protein (SCP1) from shark cartilage with anti-angiogenesis activity and sequence similarity to parvalbumin.
    Rabbani-Chadegani A; Abdossamadi S; Bargahi A; Yousef-Masboogh M
    J Pharm Biomed Anal; 2008 Feb; 46(3):563-7. PubMed ID: 18093782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shark cartilage extracts as antiangiogenic agents: smart drinks or bitter pills?
    Gingras D; Renaud A; Mousseau N; Béliveau R
    Cancer Metastasis Rev; 2000; 19(1-2):83-6. PubMed ID: 11191068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low molecular weight fraction of shark cartilage can modulate immune responses and abolish angiogenesis.
    Hassan ZM; Feyzi R; Sheikhian A; Bargahi A; Mostafaie A; Mansouri K; Shahrokhi S; Ghazanfari T; Shahabi S
    Int Immunopharmacol; 2005 Jun; 5(6):961-70. PubMed ID: 15829412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sharks: a potential source of antiangiogenic factors and tumor treatments.
    Cho J; Kim Y
    Mar Biotechnol (NY); 2002 Dec; 4(6):521-5. PubMed ID: 14961226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The characterization of angiogenesis inhibitor from shark cartilage.
    Liang JH; Wong KP
    Adv Exp Med Biol; 2000; 476():209-23. PubMed ID: 10949667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiogenic inhibitor protein fractions derived from shark cartilage.
    Bargahi A; Rabbani-Chadegani A
    Biosci Rep; 2008 Feb; 28(1):15-21. PubMed ID: 18215148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demonstration of inhibitory effect of oral shark cartilage on basic fibroblast growth factor-induced angiogenesis in the rabbit cornea.
    González RP; Soares FS; Farias RF; Pessoa C; Leyva A; de Barros Viana GS; Moraes MO
    Biol Pharm Bull; 2001 Feb; 24(2):151-4. PubMed ID: 11217082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiangiogenic and anticancer molecules in cartilage.
    Patra D; Sandell LJ
    Expert Rev Mol Med; 2012 Jan; 14():e10. PubMed ID: 22559283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiproliferative activity of shark cartilage with and without tumor necrosis factor-alpha in human umbilical vein endothelium.
    McGuire TR; Kazakoff PW; Hoie EB; Fienhold MA
    Pharmacotherapy; 1996; 16(2):237-44. PubMed ID: 8820467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shark cartilage, cancer and the growing threat of pseudoscience.
    Ostrander GK; Cheng KC; Wolf JC; Wolfe MJ
    Cancer Res; 2004 Dec; 64(23):8485-91. PubMed ID: 15574750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiangiogenic properties of a novel shark cartilage extract: potential role in the treatment of psoriasis.
    Dupont E; Savard PE; Jourdain C; Juneau C; Thibodeau A; Ross N; Marenus K; Maes DH; Pelletier G; Sauder DN
    J Cutan Med Surg; 1998 Jan; 2(3):146-52. PubMed ID: 9479080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of the fibrinolytic system by cartilage extract mediates its antiangiogenic effect in mouse glioma.
    Simard B; Bouamrani A; Jourdes P; Pernod G; Dimitriadou V; Berger F
    Microvasc Res; 2011 Jul; 82(1):6-17. PubMed ID: 21406197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiangiogenic effects of the oral administration of liquid cartilage extract in humans.
    Berbari P; Thibodeau A; Germain L; Saint-Cyr M; Gaudreau P; Elkhouri S; Dupont E; Garrel DR; Elkouri S
    J Surg Res; 1999 Nov; 87(1):108-13. PubMed ID: 10527711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel angiogenic inhibitor derived from Japanese shark cartilage (I). Extraction and estimation of inhibitory activities toward tumor and embryonic angiogenesis.
    Oikawa T; Ashino-Fuse H; Shimamura M; Koide U; Iwaguchi T
    Cancer Lett; 1990 Jun; 51(3):181-6. PubMed ID: 1693543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of shark cartilage in patients with advanced cancer: a North Central Cancer Treatment Group trial.
    Loprinzi CL; Levitt R; Barton DL; Sloan JA; Atherton PJ; Smith DJ; Dakhil SR; Moore DF; Krook JE; Rowland KM; Mazurczak MA; Berg AR; Kim GP;
    Cancer; 2005 Jul; 104(1):176-82. PubMed ID: 15912493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shark cartilage contains inhibitors of tumor angiogenesis.
    Lee A; Langer R
    Science; 1983 Sep; 221(4616):1185-7. PubMed ID: 6193581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Boron neutron capture therapy of the rat 9L gliosarcoma: evaluation of the effects of shark cartilage.
    Morris GM; Coderre JA; Micca PL; Lombardo DT; Hopewell JW
    Br J Radiol; 2000 Apr; 73(868):429-34. PubMed ID: 10844870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and sequence of the vitamin K-dependent matrix Gla protein from the calcified cartilage of the soupfin shark.
    Rice JS; Williamson MK; Price PA
    J Bone Miner Res; 1994 Apr; 9(4):567-76. PubMed ID: 8030445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of CD(4)(+) and CD(8)(+) tumor infiltrating lymphocytes by a fraction isolated from shark cartilage: shark cartilage modulates anti-tumor immunity.
    Feyzi R; Hassan ZM; Mostafaie A
    Int Immunopharmacol; 2003 Jul; 3(7):921-6. PubMed ID: 12810349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.